Advanced-stage hepatocellular carcinoma: transarterial chemoembolization versus sorafenib.
about
Transarterial chemoembolization using drug eluting beads for the treatment of hepatocellular carcinoma: Now and futureTransarterial chemoembolization: Evidences from the literature and applications in hepatocellular carcinoma patientsAdvanced hepatocellular carcinoma and sorafenib: Diagnosis, indications, clinical and radiological follow-upTransarterial radioembolization using yttrium-90 microspheres in the treatment of hepatocellular carcinoma: a review on clinical utility and developmentsManagement of hepatocellular carcinoma with portal vein thrombosisClinical trials of combined molecular targeted therapy and locoregional therapy in hepatocellular carcinoma: past, present, and futureRecommendations for the use of chemoembolization in patients with hepatocellular carcinoma: Usefulness of scoring system?Comparison of intra-arterial chemoembolization with and without radiotherapy for advanced hepatocellular carcinoma with portal vein tumor thrombosis: a meta-analysis.Barcelona clinic liver cancer nomogram and others staging/scoring systems in a French hepatocellular carcinoma cohortSorafenib combined with transarterial chemoembolization versus transarterial chemoembolization alone for advanced-stage hepatocellular carcinoma: a propensity score matching study.Barcelona clinic liver cancer-stage C hepatocellular carcinoma: A novel approach to subclassification and treatment.Risk factors and therapeutic results of early local recurrence after transcatheter arterial chemoembolizationEfficacy and safety of TACE in combination with sorafenib for the treatment of TACE-refractory advanced hepatocellular carcinoma in Chinese patients: a retrospective study.Advanced-stage hepatocellular carcinoma with portal vein thrombosis: conventional versus drug-eluting beads transcatheter arterial chemoembolization.Efficacy and safety of the FOLFOX4 regimen versus doxorubicin in Chinese patients with advanced hepatocellular carcinoma: a subgroup analysis of the EACH studyTransarterial chemoembolization for hepatocellular carcinoma with portal vein tumor thrombus: a meta-analysisTransarterial chemoembolization in unresectable hepatocellular carcinoma with portal vein thrombosis: a perspective on survival.Effective treatment strategies other than sorafenib for the patients with advanced hepatocellular carcinoma invading portal veinNew perspectives on the management of hepatocellular carcinoma with portal vein thrombosis.Radioembolization Is a Safe and Effective Treatment for Hepatocellular Carcinoma with Portal Vein Thrombosis: A Propensity Score Analysis.Hong Kong Liver Cancer Staging System Is Associated With Better Performance for Hepatocellular Carcinoma: Special Emphasis on Viral EtiologyTreatment algorithm based on the multivariate survival analyses in patients with advanced hepatocellular carcinoma treated with trans-arterial chemoembolizationThe inhibitory effect of MSCs expressing TRAIL as a cellular delivery vehicle in combination with cisplatin on hepatocellular carcinoma.Stromal targeting of sodium iodide symporter using mesenchymal stem cells allows enhanced imaging and therapy of hepatocellular carcinoma.Survival benefit of chemoembolization plus Iodine125 seed implantation in unresectable hepatitis B-related hepatocellular carcinoma with PVTT: a retrospective matched cohort study.Transcatheter arterial chemoembolization and radiation therapy for treatment-naïve patients with locally advanced hepatocellular carcinomaTransarterial chemoembolization for the treatment of advanced hepatocellular carcinoma with portal vein tumor thrombosis: prognostic factors in a single-center study of 188 patients.Clinical characteristics and prognostic factors for advanced hepatocellular carcinoma with extrahepatic metastasis.Transarterial chemoembolization in hepatocellular carcinoma with vascular invasion or extrahepatic metastasis: A systematic review.Safety and effectiveness of chemoembolization with drug-eluting beads for advanced-stage hepatocellular carcinoma.Doxorubicin -eluting beads in the treatment of liver carcinoma.Long-term survival of patients with hepatocellular carcinoma with inferior vena cava tumor thrombus treated with sorafenib combined with transarterial chemoembolization: report of two cases and literature review.Transarterial Chemoembolization for Hepatocellular Carcinomas with Central Bile Duct Invasion: Safety, Prognosis, and Predictive Factors.Current management of hepatocellular carcinoma: an Eastern perspective.Hepatocellular carcinoma imaging systems: why they exist, how they have evolved, and how they differ.Postoperative adjuvant TACE for patients of hepatocellular carcinoma in AJCC stage I: friend or foe? a propensity score analysis.Clinical implications for imaging of vascular invasion in hepatocellular carcinoma.Comparative effectiveness of traditional chemoembolization with or without sorafenib for hepatocellular carcinoma.Trends in utilization of transarterial treatments for hepatocellular carcinoma: results of a survey by the Italian Society of Interventional Radiology.Conventional vs drug-eluting beads transarterial chemoembolization for hepatocellular carcinoma.
P2860
Q26771776-66E9840E-DD34-43B7-82EA-58D9FB004750Q26799469-C5B3516C-8BFA-4630-A91C-7AED1205064BQ26851033-45513FA4-34B1-4FDC-8E9E-ADC3029C7AC5Q26852174-E874D942-1AAC-439D-8C69-D7C2ABB1857CQ26996578-69E958F2-B416-4246-8975-A0B73AF95ED0Q27013055-8FB3DE43-22EC-407A-A455-2E0FABD30A30Q27022015-E89A084D-51FF-4229-BE01-87E45AA103BFQ33438161-B2391B38-2520-4F98-AB34-B426C5A59F35Q33572657-21B67799-CE35-4E38-BBE4-CEEE52AD2ECEQ33590407-175FDC75-5C74-4106-B8F5-D76F2DE81E76Q33627217-0F47D990-6E96-437A-A820-1EEFFFFB65ECQ33735369-AAC4C323-D7E3-4ADA-928C-30B72A2CCD6BQ33758258-53D3B04B-F716-4C13-A268-2FFA7C152199Q33797067-63B3D312-5BDE-4E31-8781-7B0DD459C470Q34458029-06A6F154-0806-4F30-AF1F-F87E9F0A950CQ34659148-1F8CBED4-0F8F-4D25-82E1-B01328D7394AQ34900004-079F5508-559C-4423-AF95-635F00F75433Q35715947-898DB3AC-57E5-47A2-875A-B702CE8F070AQ35824064-8027A787-AF04-4D75-8261-5FD02723F51EQ36009432-B2331028-BE23-4EE6-9E72-22E6441E92A2Q36195552-6F6D23CE-AA74-47E9-99E5-28C043B7C945Q36272834-B28299BB-927E-4472-A511-5DC2D25DB1CBQ36312145-6C3D44C5-20C9-4B3C-9750-C286F9683294Q36720696-CD9FA0D5-D5EF-4054-A2CD-F8445849FBEDQ37253643-0B642142-3F86-4FF5-AC9C-A5EE1A1CB703Q37687300-7CDCFB40-5F48-45A2-9025-DAEB5F39A9B3Q37718937-98D58847-368C-42E5-9337-D8DB9E89F4A4Q37722175-1E0DF820-CAB7-495E-93B0-DA9C26F08BF8Q38109951-779788B6-F0B6-40F4-8EEB-4F7923AAF30BQ38113503-72E7D60D-FEF4-43F8-BCAA-FC718B9B3DC2Q38161583-FB3D3917-DDEC-4C99-9824-5C44AB52D6ACQ38170197-1950B5F3-C655-40F1-BF07-4A10CB6795FDQ38281294-D2AB56A8-FCD4-4FCF-9D6D-7F9427D926CAQ38410816-10A2ED41-9F15-4AFF-B9E3-0E4542E44549Q38608806-926198D3-795F-4395-B087-F605ADECA98BQ38810775-AB971A58-D98A-4FE8-A855-98EBB35B0631Q38824638-98FCA50E-94A4-4645-97D8-CCF234B5E1FBQ39375746-712152CE-B2C5-4D06-A84C-AB315F759E47Q39410889-0BEBA8FE-B9CC-46E8-A7A7-51E449DE50BDQ39434012-B6F5C3B1-6552-4BFA-80A5-E68BA3883393
P2860
Advanced-stage hepatocellular carcinoma: transarterial chemoembolization versus sorafenib.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Advanced-stage hepatocellular ...... embolization versus sorafenib.
@en
Advanced-stage hepatocellular ...... embolization versus sorafenib.
@nl
type
label
Advanced-stage hepatocellular ...... embolization versus sorafenib.
@en
Advanced-stage hepatocellular ...... embolization versus sorafenib.
@nl
prefLabel
Advanced-stage hepatocellular ...... embolization versus sorafenib.
@en
Advanced-stage hepatocellular ...... embolization versus sorafenib.
@nl
P2093
P356
P1433
P1476
Advanced-stage hepatocellular ...... embolization versus sorafenib.
@en
P2093
Andreas Maieron
Birgit Grünberger
Christian Müller
Claus Kölblinger
Florian Hucke
Ivo Graziadei
Matthias Pinter
Robert Königsberg
Rudolf Stauber
Wolfgang Sieghart
P304
P356
10.1148/RADIOL.12111550
P407
P577
2012-03-21T00:00:00Z